NEUROLOGIE PRO PRAXI / Neurol. praxi. 2025;26(1):24-30 / www.neurologiepropraxi.cz 30 HLAVNÍ TÉMA Genetika frontotemporálnej demencie 14. Josephs KA, Hodges JR, Snowden JS, et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011;122(2):137-53. 15. Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006;66:41-48. 16. Kashyap SN, Boyle NR, Roberson ED. Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations. Neurotherapeutics. 2023;20(1):140-153. doi:10.1007/s13311-023-01348-6. 17. Kertesz A, McMonagle P, Blair M, et al. The evolution and pathology of frontotemporal dementia. Brain. 2005; 128:1996–2005. 18. Lagier-Tourenne C, Polymenidou M, Hutt KR, et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP43 intersect in processing long pre-mRNAs. Nat Neurosci. 2012;15(11):1488-97. 19. Le Ber I, De Septenville A, Guerreiro R, et al. Homozygous TREM2 mutation in a family with atypical frontotemporal dementia. Neurobiol Aging. 2014 Oct;35(10):2419. e23-2419.e25. 20. Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010;119:1-4. 21. Majounie E, Renton AE, Mok K, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11(4):323-30. 22. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546-54. 23. Polymenidou M, Lagier-Tourenne C, Hutt KR, et al. Long pre- -mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci. 2011;14(4):459-68. 24. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(Pt 9):2456-77. 25. Rayaprolu S, Mullen B, Baker M, et al. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener. 2013;8:19. Published 2013 Jun 21. doi:10.1186/17501326-8-19. 26. Rektorová I. Frontotemporální lobární degenerace – diagnóza z neuro-psychiatrického pomezí. Neurol. prax. 2006;7(4):208-211. 27. Rizzu P, Van Swieten JC, Joosse M, et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet. 1999;64(2):414-21. 28. Sanders J, Schenk V, van Veen P. A family with Pick disease. Veerhandelingen de Koninklijike Nederlandese Akademie van Wetenschappen. 1939. 29. Sieben A, Van Langenhove T, Engelborghs S, et al. The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol. 2012;124(3):353-72. 30. Silvaieh S, König T, Wurm R, et al. Comprehensive genetic screening of early-onset dementia patients in an Austrian cohort-suggesting new disease-contributing genes. Hum Genomics. 2023;17(1):55. Published 2023 Jun 17. doi:10.1186/ s40246-023-00499-z. 31. Snowden J, Neary D, Mann D Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol. 2007;114:31-38. 32. Snowden JS, Bathgate D, Varma A, et al. Distinct behavioral profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry. 2001;70:323-332. 33. Snowden JS, Thompson JC, Stopford CL, et al. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. Brain. 2011;134(Pt 9):2478-92. 34. Šutovský S, Malík M, Traubner P, Turčáni P. Primárna progresívna afázia – zriedkavá alebo poddiagnistikovaná. Neurol. prax. 2007;8(3):170-173. 35. Taskesen E, Mishra A, van der Sluis S, et al. Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS. Sci Rep. 2017;7(1):8899. Published 2017 Aug 21. doi:10.1038/ s41598-017-09320-z. 36. Ticozzi N, Silani V, LeClerc AL, et al. Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort. Neurology. 2009;73(15):1180-1185. doi:10.1212/ WNL.0b013e3181bbff05. 37. Winfree RL, Seto M, Dumitrescu L, et al. TREM2 gene expression associations with Alzheimer's disease neuropathology are region-specific: implications for cortical versus subcortical microglia. Acta Neuropathol. 2023;145(6):733-747. doi:10.1007/ s00401-023-02564-2. 38. Xie M, Liu YU, Zhao S, et al. TREM2 interacts with TDP43 and mediates microglial neuroprotection against TDP- -43-related neurodegeneration. Nat Neurosci. 2022;25(1):2638. doi:10.1038/s41593-021-00975-6. 39. Xiao X, Li M, Ye Z, et al. FUS gene mutation in amyotrophic lateral sclerosis: A new case report and systematic review. Amyotroph. Lateral Scler. Frontotemporal Degener. 2024;25:1-15. ODBORNÝ GARANT: doc. MUDr. Irena Doležalová, Ph.D. POŘADATEL: Společnost SOLEN, s. r. o., ve spolupráci s I. neurologickou klinikou LF MU a FN u sv. Anny ZLATÝ PARTNER Registrace ZDARMA TERMÍN květen 2024 až duben 2025 ON LINE KURZ OBSAH KURZU Co víme o syndromu Dravetové u dospělých? – prof. MUDr. Petr Marusič, Ph.D. Na co ještě myslet u dětí? – MUDr. Martin Kudr, Ph.D. Cesta k diagnóze – dialog s genetikem – MUDr. Katalin Štěrbová Cesta k diagnóze – dialog s genetikem – MUDr. Jana Zárubová Cesta k diagnóze – dialog s genetikem – MUDr. Markéta Vlčková, Ph.D. Mechanismus účinku a protizáchvatová aktivita fen uraminu – MUDr. Ondřej Horák, doc. MUDr. Irena Doležalová, Ph.D. Zaostřeno na syndrom Dravetové dostupný na online.solen.cz
RkJQdWJsaXNoZXIy NDA4Mjc=